Recent Finacing
Recent Raise
Thymmune Therapeutics is developing off-the-shelf induced-pluripotent-stem-cell-derived thymus cell therapies to reboot and restore human immune function.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Thymmune Therapeutics.
